Industry Podcasts – Carevive

The OCM (Oncology Care Model), launched in 2016, is a payment model designed to help oncology centers transition from the traditional Medicare Fee-for-Service (FFS) payment structure and focus on high-value care. The EOM (Enhancing Oncology Model) is the next phase model and will replace OCM starting July 1, 2023. EOM will support clinicians caring for…

Quality cancer care is important to the well-being of cancer patients, and the government is working to increase the efficiency of care. In a recent Carevive podcast episode, host Michelle Dawn Mooney chatted with Carevive’s Founder and Vice Chairman, Madelyn Herzfeld, about the Enhancing Oncology Model, or EOM. Through the Centers for Medicare and Medicaid…

The ONS Congress brings together various skillsets and inspires innovation in new ways. With the first in-person Congress since the pandemic set to begin on April 27th, there is much to look forward to. John Elliott, VP of Sales with Carevive brings together his work colleagues to share their excitement for the Congress and what…

Cancer treatment and care can be complex and often focuses on quality of life. The ecosystem of care delivery touches many aspects, and most of these can see improvement with the power of data. Discussing the topic, Oncology and Technology host James Kent spoke with Aaron Galaznik, MD, Chief Scientific Officer of Carevive. Galaznik was…

John Elliott, VP, Sales at Carevive spoke with Host Daniel J. Litwin on his observations about the industry at the HLTH 2021 Tradeshow in Boston, Mass. Elliott noted many positive trends during the show and will benefit all in the industry, but most importantly the patients. The biggest takeaways from the show in Elliott’s opinion…

Patients utilizing Carevive’s PROmpt engagement tool and ePRO systems now have an assistant they can rely on to help them. Meet CLARA, Carvive’s Longitudinal Assessments, and Reporting Assistant. SarahLena Keckler, Director of Product Management at Carevive, and Nadia Still, Carevive’s Senior Director of Client Success, walked Oncology and Technology’s James Kent through how CLARA came…